Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-129-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 549, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
SOX4 hsa-miR-129-5p low: 4 high: 11 3 4 3 -
Low-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Yi-Wen Huang et al. 2009 WB RP Uterus/Endometrium ISHIKAWA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
chr6:21595960-21598619 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
Yi-Wen Huang et al. 2009 WB RP Uterus/Endometrium ECC1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
chr6:21595960-21598619 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
High-throughput experiments (11 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Yi-Wen Huang et al. 2009 MA Uterus/Endometrium ISHIKAWA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Microarrays POSITIVE INDIRECT TarBase 7.0
Yi-Wen Huang et al. 2009 MA Uterus/Endometrium ECC1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Microarrays POSITIVE INDIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:21598480-21598502 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:21597997-21598019 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:21596260-21596282 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:21598480-21598502 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:21596059-21596080 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:21598480-21598502 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:21596260-21596282 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:21594114-21594142 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:21596260-21596282 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FMR1 hsa-miR-129-5p low: 4 high: 0 1 2 2 -
Low-throughput experiments (3 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Samantha Zongaro et al. 2013 WB qP Brain MPN10 5510 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot NEGATIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Samantha Zongaro et al. 2013 qP Cervix HELA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
Samantha Zongaro et al. 2013 RP Cervix HELA HELA N/A
Location Method Result Regulation Validation Type Source
chrX:147949286-147949407 Luciferase Reporter Assay POSITIVE DIRECT TarBase 7.0
UBE2F hsa-miR-129-5p low: 2 high: 0 1 2 1 -
Low-throughput experiments (0 positive, 2 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Yi-Wen Huang et al. 2009 RP Uterus/Endometrium ISHIKAWA N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 7.0
Yi-Wen Huang et al. 2009 RP Uterus/Endometrium ECC1 N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 7.0
ABCB1 hsa-miR-129-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Wu Q. et al. 2014 RP Gastric SGC7901 SGC7901 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
ABCC5 hsa-miR-129-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Wu Q. et al. 2014 RP Gastric SGC7901 SGC7901 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
ABCG1 hsa-miR-129-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Wu Q. et al. 2014 RP Gastric SGC7901 SGC7901 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay POSITIVE DIRECT TarBase 8.0
CMTR2 hsa-miR-129-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:71284694-71284719 Chimeric fragments POSITIVE DIRECT TarBase 8.0
CEP97 hsa-miR-129-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:101765838-101765862 Chimeric fragments POSITIVE DIRECT TarBase 8.0
TNRC6A hsa-miR-129-5p low: 0 high: 10 1 1 1 -
High-throughput experiments (10 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:24824659-24824682 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24750755-24750778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:24824867-24824885 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24824857-24824880 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24750755-24750778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:24750755-24750778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24750755-24750778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:24824659-24824682 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24750755-24750778 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:24750743-24750771 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF703 hsa-miR-129-5p low: 0 high: 8 1 1 1 0.877
High-throughput experiments (8 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr8:37698877-37698898 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HOXB9 hsa-miR-129-5p low: 0 high: 7 2 2 2 0.790
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:48621188-48621212 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:48621194-48621212 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:48621188-48621212 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:48623089-48623114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:48621188-48621212 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:48621194-48621212 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:48621180-48621199 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HOXA10 hsa-miR-129-5p low: 0 high: 7 1 1 1 0.733
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr7:27171232-27171257 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:27170646-27170671 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:27170646-27170671 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr7:27170818-27170842 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:27170646-27170671 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:27170646-27170671 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:27170646-27170671 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DTL hsa-miR-129-5p low: 0 high: 7 1 1 1 0.796
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:212062925-212062947 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPL32 hsa-miR-129-5p low: 0 high: 6 1 1 1 0.492
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr3:12839433-12839458 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BSDC1 hsa-miR-129-5p low: 0 high: 6 1 1 1 0.864
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:32368032-32368057 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:32368024-32368037 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:32365232-32365251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:32365223-32365251 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:32365215-32365237 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:32365215-32365237 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RRAGD hsa-miR-129-5p low: 0 high: 5 1 1 1 0.954
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr6:89367870-89367892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr6:89367870-89367892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:89367870-89367892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:89367870-89367892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:89367870-89367892 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LARP1 hsa-miR-129-5p low: 0 high: 5 2 2 2 0.892
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:154814856-154814877 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:154814856-154814877 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:154814856-154814877 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:154814844-154814867 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:154817396-154817423 HITS-CLIP POSITIVE DIRECT TarBase 7.0
YAP1 hsa-miR-129-5p low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:102233177-102233205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:102233177-102233205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:102233177-102233205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:102233177-102233205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:102233177-102233205 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ITGA2 hsa-miR-129-5p low: 0 high: 5 1 1 1 0.888
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:53094540-53094557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:53094568-53094589 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:53094540-53094557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:53094540-53094557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:53094540-53094557 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C16orf80 hsa-miR-129-5p low: 0 high: 5 1 1 1 0.659
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:58113944-58113963 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:58113944-58113963 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:58113944-58113963 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:58113944-58113963 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:58113944-58113963 HITS-CLIP POSITIVE DIRECT TarBase 7.0